Cardiac Valve and Other Major Cardiothoracic Procedures DRG Reimbursement

Acute perioperative intervention trials assessing strategies to reduce intraoperative and immediate postoperative complications in patients undergoing cardiac valve surgery with concurrent cardiac catheterization. These studies typically enroll high-risk adults with severe valvular disease who require valve repair or replacement and concomitant diagnostic or interventional catheterization, and they test interventions such as optimized cardioplegia protocols, hemodynamic monitoring approaches, or fast-track anesthesia pathways. Findings are relevant to providers for refining surgical and anesthetic management to lower morbidity and to payers because reduced perioperative complications and shorter ICU stays can meaningfully affect cost and resource utilization for this high-cost DRG.
Comparative effectiveness research comparing valve procedure approaches and timing in patients who undergo combined cardiothoracic surgery and catheterization, including comparisons of surgical techniques (e.g., repair versus replacement, biologic versus mechanical prostheses) or staged versus concomitant catheter-based diagnostics/interventions. These studies enroll heterogeneous populations (elderly patients, those with multivalvular disease, or with coronary artery disease discovered at catheterization) to determine which approaches yield better survival, fewer rehospitalizations, and lower complication rates. Results inform clinical decision-making and guideline development, helping providers choose strategies that balance clinical benefit with downstream costs and readmission risk that impact payer reimbursement under bundled payments.
Post-discharge outcomes and care-transition studies focused on medium- to long-term recovery, anticoagulation management, and readmission prevention for patients after major cardiothoracic valve procedures with catheterization, often using registry-based cohorts or pragmatic trials of transitional care interventions. These studies examine patients discharged after complicated index admissions (including those with major complications coded as MCC), evaluating interventions such as structured follow-up, home-monitoring, or coordinated anticoagulation clinics to reduce thromboembolic events, bleeding, and early readmissions. Evidence from this research is important to providers to optimize outpatient care plans and to payers because improved post-discharge outcomes can reduce costly readmissions and improve value for episodes of care covered under DRG-based payment models.

Acute perioperative intervention trials assessing strategies to reduce intraoperative and immediate postoperative complications in patients undergoing cardiac valve surgery with concurrent cardiac catheterization. These studies typically enroll high-risk adults with severe valvular disease who require valve repair or replacement and concomitant diagnostic or interventional catheterization, and they test interventions such as optimized cardioplegia protocols, hemodynamic monitoring approaches, or fast-track anesthesia pathways. Findings are relevant to providers for refining surgical and anesthetic management to lower morbidity and to payers because reduced perioperative complications and shorter ICU stays can meaningfully affect cost and resource utilization for this high-cost DRG.
Comparative effectiveness research comparing valve procedure approaches and timing in patients who undergo combined cardiothoracic surgery and catheterization, including comparisons of surgical techniques (e.g., repair versus replacement, biologic versus mechanical prostheses) or staged versus concomitant catheter-based diagnostics/interventions. These studies enroll heterogeneous populations (elderly patients, those with multivalvular disease, or with coronary artery disease discovered at catheterization) to determine which approaches yield better survival, fewer rehospitalizations, and lower complication rates. Results inform clinical decision-making and guideline development, helping providers choose strategies that balance clinical benefit with downstream costs and readmission risk that impact payer reimbursement under bundled payments.
Post-discharge outcomes and care-transition studies focused on medium- to long-term recovery, anticoagulation management, and readmission prevention for patients after major cardiothoracic valve procedures with catheterization, often using registry-based cohorts or pragmatic trials of transitional care interventions. These studies examine patients discharged after complicated index admissions (including those with major complications coded as MCC), evaluating interventions such as structured follow-up, home-monitoring, or coordinated anticoagulation clinics to reduce thromboembolic events, bleeding, and early readmissions. Evidence from this research is important to providers to optimize outpatient care plans and to payers because improved post-discharge outcomes can reduce costly readmissions and improve value for episodes of care covered under DRG-based payment models.

OpenPayer

Summary & Overview

Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with MCC: Inpatient Reimbursement Overview

DRG 216 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes